PRXL : Summary for PAREXEL International Corporati - Yahoo Finance

U.S. Markets closed

PAREXEL International Corporation (PRXL)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
63.83+0.46 (+0.73%)
At close: 4:00PM EDT
People also watch
ICLRCRLTECHUTHRMDCO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close63.37
Open63.29
Bid52.40 x 100
Ask64.50 x 100
Day's Range62.98 - 63.96
52 Week Range51.16 - 72.32
Volume369,784
Avg. Volume968,912
Market Cap3.25B
Beta0.66
PE Ratio (TTM)22.65
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire12 days ago

    Parexel International Announces Date of Third Quarter Fiscal Year 2017 Earnings Release and Conference Call

    PAREXEL International Corporation will release financial results for the Third Quarter Fiscal Year 2017 on Wednesday, May 3, 2017 after the close of the stock market.

  • TheStreet.com19 days ago

    Parexel Is Discovering the Drugs of the Future

    The midcap drug maker is finding growth as an outsourcing destination.

  • American City Business Journals26 days ago

    Triangle CROs among best to work with, says survey

    Triangle-based contract research organizations and those with big local bases top the list of those best to work with, according to a new survey from Boston-based clinical trials information provider CenterWatch. “The seven highest-ranking companies were PSI CRO, INC Research (INCR), Chiltern, QuintilesIMS (NYSE: Q), Parexel (PRXL), Icon and PPD,” CenterWatch said in an announcement. INC Research is based in Raleigh, and recently announced plans to move its headquarters to Morrisville as part of a 550-job expansion in the state .